14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.11 $8.20 Thursday, 2nd May 2024 GLUE stock ended at $5.60. This is 5.72% less than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 10.84% from a day low at $5.35 to a day high of $5.93.
90 days $4.19 $8.84
52 weeks $2.44 $8.84

Historical Monte Rosa Therapeutics, Inc. prices

Date Open High Low Close Volume
Dec 07, 2023 $3.03 $3.70 $2.95 $3.67 505 217
Dec 06, 2023 $3.08 $3.14 $2.97 $2.98 177 443
Dec 05, 2023 $3.07 $3.21 $2.99 $3.05 124 064
Dec 04, 2023 $3.12 $3.20 $2.99 $3.08 213 467
Dec 01, 2023 $3.13 $3.15 $2.94 $3.12 343 331
Nov 30, 2023 $3.16 $3.38 $3.04 $3.10 649 283
Nov 29, 2023 $2.99 $3.29 $2.95 $3.14 108 306
Nov 28, 2023 $2.99 $3.11 $2.95 $2.96 105 205
Nov 27, 2023 $2.93 $3.06 $2.91 $3.00 84 893
Nov 24, 2023 $3.01 $3.07 $2.97 $2.97 39 859
Nov 22, 2023 $3.09 $3.13 $2.96 $2.98 97 938
Nov 21, 2023 $3.20 $3.20 $2.95 $2.98 122 240
Nov 20, 2023 $3.36 $3.51 $3.16 $3.25 115 359
Nov 17, 2023 $3.30 $3.43 $3.29 $3.35 173 160
Nov 16, 2023 $3.68 $3.71 $3.20 $3.24 150 536
Nov 15, 2023 $3.52 $3.93 $3.52 $3.68 214 165
Nov 14, 2023 $3.26 $3.44 $3.24 $3.41 158 251
Nov 13, 2023 $3.20 $3.20 $2.98 $3.06 128 725
Nov 10, 2023 $3.30 $3.30 $2.97 $3.21 153 428
Nov 09, 2023 $3.67 $3.78 $3.29 $3.30 167 490
Nov 08, 2023 $3.60 $3.72 $3.47 $3.69 232 321
Nov 07, 2023 $3.38 $3.68 $3.37 $3.55 203 549
Nov 06, 2023 $3.63 $3.63 $3.28 $3.32 243 887
Nov 03, 2023 $3.60 $3.81 $3.54 $3.58 248 469
Nov 02, 2023 $3.44 $3.58 $3.36 $3.47 142 754
Click to get the best stock tips daily for free!

About Monte Rosa Therapeutics, Inc.

Monte Rosa Therapeutics. Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, ... GLUE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT